Latest ObesityTreatment News and Updates : ObesityTreatment updates, ObesityTreatment News , ObesityTreatment around the world

Nishadil

Washington | 20°C (light rain)

Why Medicaid Cuts Are Leaving Millions Without Access to GLP‑1 Weight‑Loss Meds

Top story

Why Medicaid Cuts Are Leaving Millions Without Access to GLP‑1 Weight‑Loss Meds

In focus

Latest feed

Eli Lilly's Retatrutide: The Next Big Leap in Weight Management

Double Standard Over GLP‑1 Drugs Hits Women Especially Hard

The GLP-1 Dilemma: Unpacking Why Your Health Plan Isn't Covering Breakthrough Weight Loss Drugs

A Glimmer of Hope: How Weight-Loss Drugs Might Save Limbs

Latest headlines

A Game Changer for Health? California Kicks Off Medicare Pilot to Cover Weight Loss Meds

A Game Changer for Health? California Kicks Off Medicare Pilot to Cover Weight Loss Meds

Medicare's Landmark Pilot: Weight-Loss Drugs Now Covered for Heart Health

Medicare's Landmark Pilot: Weight-Loss Drugs Now Covered for Heart Health

Medicare Takes a Landmark Step: Pilot Program to Cover Weight-Loss Drugs for Heart Patients

Medicare Takes a Landmark Step: Pilot Program to Cover Weight-Loss Drugs for Heart Patients

The GLP-1 Revolution: A Budgetary Tightrope for Medicare and Medicaid

The GLP-1 Revolution: A Budgetary Tightrope for Medicare and Medicaid

The GLP-1 Revolution: A Financial Tightrope for Medicare and Medicaid

The GLP-1 Revolution: A Financial Tightrope for Medicare and Medicaid

Medicare's Landmark Shift: Finally Covering Ozempic-Style Drugs for Cardiovascular Health

Medicare's Landmark Shift: Finally Covering Ozempic-Style Drugs for Cardiovascular Health

The Weight Loss Drug Revolution: Navigating a Fast-Evolving Market

The Weight Loss Drug Revolution: Navigating a Fast-Evolving Market

The Weight of Progress: Employers Grapple with GLP-1 Costs and Coverage

The Weight of Progress: Employers Grapple with GLP-1 Costs and Coverage

The Weight of Wellness: How GLP-1 Costs Are Reshaping Employer Healthcare

The Weight of Wellness: How GLP-1 Costs Are Reshaping Employer Healthcare

The Road Ahead for Semaglutide Generics: Why API Capacity Is the Real Game‑Changer, Says Goldman Sachs

The Road Ahead for Semaglutide Generics: Why API Capacity Is the Real Game‑Changer, Says Goldman Sachs

A New Chapter for Weight Loss: WW Leans into GLP-1s as Eli Lilly Explores Wider Medical Miracles

A New Chapter for Weight Loss: WW Leans into GLP-1s as Eli Lilly Explores Wider Medical Miracles

Medicare’s $50 GLP‑1 Weight‑Loss Plan: What the Numbers Really Mean

Medicare’s $50 GLP‑1 Weight‑Loss Plan: What the Numbers Really Mean

Retatrutide: A New Era in Weight Loss, But What Are We Really Losing?

Retatrutide: A New Era in Weight Loss, But What Are We Really Losing?

Hope on the Horizon: Edmonton Now Offers Endoscopic Sleeve Gastroplasty for Weight Loss

Hope on the Horizon: Edmonton Now Offers Endoscopic Sleeve Gastroplasty for Weight Loss

The Weight Loss Revolution: Eli Lilly Unveils a New Horizon

The Weight Loss Revolution: Eli Lilly Unveils a New Horizon

The Next Frontier in Weight Loss: Eli Lilly's Latest Innovation

The Next Frontier in Weight Loss: Eli Lilly's Latest Innovation

Navigating the Hype: Are Popular Weight Loss Medications Right for *You*?

Navigating the Hype: Are Popular Weight Loss Medications Right for *You*?

Metavia Accelerates Global Battle Against Obesity and NASH with Advanced Clinical Trial

Metavia Accelerates Global Battle Against Obesity and NASH with Advanced Clinical Trial

The Weight Loss Revolution: Novo Nordisk's CEO Declares We've Only Just Begun

The Weight Loss Revolution: Novo Nordisk's CEO Declares We've Only Just Begun

A New Dawn for Weight Loss? FDA Greenlights Game-Changing Oral GLP-1 Pill!

A New Dawn for Weight Loss? FDA Greenlights Game-Changing Oral GLP-1 Pill!

Innovation Over Imitation: Novo Nordisk's Bold Bet in India's Healthcare Landscape

Innovation Over Imitation: Novo Nordisk's Bold Bet in India's Healthcare Landscape

Eli Lilly's Retatrutide Triumphs in Key Diabetes Trial, Poised to Reshape Obesity Treatment Landscape

Eli Lilly's Retatrutide Triumphs in Key Diabetes Trial, Poised to Reshape Obesity Treatment Landscape

GLP-1 Medications: The Unveiling Truth About Sustaining Heart Health Benefits

GLP-1 Medications: The Unveiling Truth About Sustaining Heart Health Benefits

The Dawn of a New Era: Accessible Obesity Treatment for All

The Dawn of a New Era: Accessible Obesity Treatment for All

CagriSema: Is Novo Nordisk's New Weight-Loss Drug the Breakthrough We've Been Waiting For?

CagriSema: Is Novo Nordisk's New Weight-Loss Drug the Breakthrough We've Been Waiting For?

The 'Skinny Pen' Phenomenon: A Look at India's Weight Loss Drug Revolution

The 'Skinny Pen' Phenomenon: A Look at India's Weight Loss Drug Revolution

The Weight-Loss Drug Wars: Novo Nordisk Eyes Vials for Wegovy in High-Stakes Battle

The Weight-Loss Drug Wars: Novo Nordisk Eyes Vials for Wegovy in High-Stakes Battle

Novo Nordisk CEO Projects Strong Supply for Game-Changing Wegovy Pill

Novo Nordisk CEO Projects Strong Supply for Game-Changing Wegovy Pill

Unpacking GLP-1 Drugs: A Human's Guide to the Latest Metabolic Marvels

Unlocking Access: Tomorrow'sRx Bridges the Gap to Affordable Weight Management with Compounded GLP-1s

Unlocking Access: Tomorrow'sRx Bridges the Gap to Affordable Weight Management with Compounded GLP-1s

The Ozempic Phenomenon: Navigating the Hype Around New Weight Loss Drugs

The Ozempic Phenomenon: Navigating the Hype Around New Weight Loss Drugs

A New Era in Obesity Treatment: The Rise of Oral Weight-Loss Solutions

A New Era in Obesity Treatment: The Rise of Oral Weight-Loss Solutions

The Ozempic Rebound: Why Weight Often Creeps Back After Stopping GLP-1 Medications

The Ozempic Rebound: Why Weight Often Creeps Back After Stopping GLP-1 Medications

The Rebound Effect: What Happens When You Stop Taking Popular Weight-Loss Medications?

The Rebound Effect: What Happens When You Stop Taking Popular Weight-Loss Medications?

A New Chapter in Weight Management: The Oral Wegovy Alternative Arrives

A New Chapter in Weight Management: The Oral Wegovy Alternative Arrives

The Oral Wegovy: Hype, Hope, and Honest Conversations About the New Weight Loss Pill

The Oral Wegovy: Hype, Hope, and Honest Conversations About the New Weight Loss Pill

Novo Nordisk's Bold Gambit: Wegovy Price Slashed by Half for China Debut

Novo Nordisk's Bold Gambit: Wegovy Price Slashed by Half for China Debut

The Future is Oral: Why Novo Nordisk's Wegovy Pill is a Game-Changer

The Future is Oral: Why Novo Nordisk's Wegovy Pill is a Game-Changer

Load more